BFRIW vs EIX · rev $37.3M vs P/E 7.3, rev $17.60B
Biofrontera Inc. Warrants (BFRIW) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Biofrontera Inc. Warrants (BFRIW) is a drug manufacturers - specialty & generic company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported BFRIW revenue for 2024-12-31 was $37.3M. Net income was -$17.8M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. BFRIW currently screens at market cap $0.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
BFRIW currently screens at market cap $0. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the BFRIW and EIX stock pages for the full models.
Not investment advice.